Runben Biotechnology released its first-quarter performance, with a net profit attributable to the parent company of 44.2 million yuan, a year-on-year increase of 24.60%
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, Runben Biotechnology disclosed its first-quarter report for 2025, showing that the company achieved revenue of 240 million yuan during the reporting period, a year-on-year increase of 44%; net profit attributable to the parent company was 44.2 million yuan, a year-on-year increase of 24.60%; and net profit excluding non-recurring gains and losses was 38.62 million yuan, a year-on-year increase of 22.85%. Basic earnings per share were 0.11 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments